Healthcare should embrace imitation, not innovation

 

Healthcare should focus more on imitation and less on innovation, according to an article published in Harvard Business Review.

Innovation has a downside; organizations that focus too much on it often miss out on chances to copy approaches that are proven to work, according to the authors.

Read more below:

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.